BE721141A - - Google Patents

Info

Publication number
BE721141A
BE721141A BE721141DA BE721141A BE 721141 A BE721141 A BE 721141A BE 721141D A BE721141D A BE 721141DA BE 721141 A BE721141 A BE 721141A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE721141A publication Critical patent/BE721141A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BE721141D 1967-09-26 1968-09-20 BE721141A (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR122284 1967-09-26

Publications (1)

Publication Number Publication Date
BE721141A true BE721141A (cg-RX-API-DMAC7.html) 1969-03-03

Family

ID=8638987

Family Applications (1)

Application Number Title Priority Date Filing Date
BE721141D BE721141A (cg-RX-API-DMAC7.html) 1967-09-26 1968-09-20

Country Status (10)

Country Link
US (1) US3608071A (cg-RX-API-DMAC7.html)
AT (1) AT282822B (cg-RX-API-DMAC7.html)
BE (1) BE721141A (cg-RX-API-DMAC7.html)
CH (1) CH492786A (cg-RX-API-DMAC7.html)
DE (1) DE1792600A1 (cg-RX-API-DMAC7.html)
DK (1) DK122970B (cg-RX-API-DMAC7.html)
FR (1) FR1604134A (cg-RX-API-DMAC7.html)
GB (1) GB1243383A (cg-RX-API-DMAC7.html)
LU (1) LU56939A1 (cg-RX-API-DMAC7.html)
NL (1) NL6813543A (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2181426B1 (cg-RX-API-DMAC7.html) * 1972-04-06 1974-12-20 Pasteur Institut
US4016252A (en) * 1972-04-06 1977-04-05 Institut Pasteur Calcium phosphate gel for adsorbing vaccines
US4070454A (en) * 1973-05-04 1978-01-24 Agence Nationale De Valorisation De La Recherche (Anvar) Vaccines, the process for preparing the same and the applications thereof
FR2227861B1 (cg-RX-API-DMAC7.html) * 1973-05-04 1976-07-02 Anvar
US3874999A (en) * 1973-10-31 1975-04-01 American Cyanamid Co Process for the purification of virus vaccine
US3978209A (en) * 1975-03-24 1976-08-31 Merck & Co., Inc. Endotoxin free meningococcus polysaccharides
DE2843963A1 (de) * 1978-10-09 1980-04-24 Merck Patent Gmbh Im koerper resorbierbare geformte masse auf basis von kollagen und ihre verwendung in der medizin
DE2807132C2 (de) * 1978-02-20 1983-11-03 Battelle-Institut E.V., 6000 Frankfurt Implantierbares Pharmaka-Depot
US4273762A (en) * 1979-12-03 1981-06-16 Merck & Co., Inc. Lyophilization process for live viral compositions
US5101019A (en) * 1987-05-22 1992-03-31 Takeda Chemical Industries, Ltd. Method for removing pertussis endotoxin, a pertussis toxoid and its production
US8333996B2 (en) 1995-05-19 2012-12-18 Etex Corporation Calcium phosphate delivery vehicle and adjuvant
US8728536B2 (en) * 1996-10-16 2014-05-20 Etex Corporation Chemotherapeutic composition using nanocrystalline calcium phosphate paste
EP1615596B1 (en) * 2003-04-11 2016-11-02 Etex Corporation Osteoinductive bone material
AU2004249802B2 (en) * 2003-06-20 2007-06-28 Microbix Biosystems Inc. Improvements in virus production
KR101218454B1 (ko) * 2004-04-15 2013-01-04 에텍스 코포레이션 세팅 지연 칼슘 포스페이트 페이스트
US8147860B2 (en) 2005-12-06 2012-04-03 Etex Corporation Porous calcium phosphate bone material

Also Published As

Publication number Publication date
US3608071A (en) 1971-09-21
DK122970B (da) 1972-05-01
AT282822B (de) 1970-07-10
LU56939A1 (cg-RX-API-DMAC7.html) 1969-01-04
DE1792600A1 (de) 1971-11-25
NL6813543A (cg-RX-API-DMAC7.html) 1969-03-28
CH492786A (fr) 1970-06-30
GB1243383A (en) 1971-08-18
FR1604134A (cg-RX-API-DMAC7.html) 1971-07-12

Similar Documents

Publication Publication Date Title
FR1604134A (cg-RX-API-DMAC7.html)
BE709259A (cg-RX-API-DMAC7.html)
BE709692A (cg-RX-API-DMAC7.html)
BE708671A (cg-RX-API-DMAC7.html)
BE708599A (cg-RX-API-DMAC7.html)
BE697273A (cg-RX-API-DMAC7.html)
BE710063A (cg-RX-API-DMAC7.html)
BE709491A (cg-RX-API-DMAC7.html)
BE711259A (cg-RX-API-DMAC7.html)
BE705443A (cg-RX-API-DMAC7.html)
BE705526A (cg-RX-API-DMAC7.html)
BE709987A (cg-RX-API-DMAC7.html)
BE707632A (cg-RX-API-DMAC7.html)
BE703264A (cg-RX-API-DMAC7.html)
BE710007A (cg-RX-API-DMAC7.html)
BE706844A (cg-RX-API-DMAC7.html)
BE709050A (cg-RX-API-DMAC7.html)
BE614676A (cg-RX-API-DMAC7.html)
BE710367A (cg-RX-API-DMAC7.html)
BE702129A (cg-RX-API-DMAC7.html)
BE708110A (cg-RX-API-DMAC7.html)
BE710030A (cg-RX-API-DMAC7.html)
BE699333A (cg-RX-API-DMAC7.html)
BE709647A (cg-RX-API-DMAC7.html)
BE693430A (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: INSTITUT PASTEUR (ETS. RECONNU D UTILITE PUBLIQUE

Effective date: 19880920